Seldi-tof MS Profiling of Plasma Proteins in Ovarian Cancer
Objective: Proteomic profiling of plasma or serum is a technique to identify new biomarkers in disease. The objective of this study was to identify new plasma biomarkers in ovarian cancer patients using mass spectrometry protein profiling and artificial intelligence. Methods: A total of 65 plasma sa...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2006-03-01
|
Series: | Taiwanese Journal of Obstetrics & Gynecology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1028455909601868 |
id |
doaj-56a21c085d264aa1affee7a99368a2bc |
---|---|
record_format |
Article |
spelling |
doaj-56a21c085d264aa1affee7a99368a2bc2020-11-24T22:35:56ZengElsevierTaiwanese Journal of Obstetrics & Gynecology1028-45592006-03-01451263210.1016/S1028-4559(09)60186-8Seldi-tof MS Profiling of Plasma Proteins in Ovarian CancerShao-Pai Wu0Ya-Wen Lin1Hung-Cheng Lai2Tang-Yuan Chu3Yu-Liang Kuo4Hang-Seng Liu5Department of Obstetrics and Gynecology, Army Forces Tao-Yuan General Hospital, Tao-Yuan, Taipei, TaiwanGraduate Institute of Medical Sciences, National Defense Medical Center, Taipei, TaiwanDepartment of Obstetrics and Gynecology, Tri-Service General Hospital, Taipei, TaiwanGraduate Institute of Medical Sciences, National Defense Medical Center, Taipei, TaiwanDepartment of Obstetrics and Gynecology, Army Forces Tao-Yuan General Hospital, Tao-Yuan, Taipei, TaiwanDepartment of Obstetrics and Gynecology, Army Forces Tao-Yuan General Hospital, Tao-Yuan, Taipei, TaiwanObjective: Proteomic profiling of plasma or serum is a technique to identify new biomarkers in disease. The objective of this study was to identify new plasma biomarkers in ovarian cancer patients using mass spectrometry protein profiling and artificial intelligence. Methods: A total of 65 plasma samples obtained from women with ovarian cancer (n = 35) and age-matched disease-free controls (n = 30) were applied to anion exchange protein chips for protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS). Results: SELDI-TOF MS was highly reproducible in detecting ovarian tumor-specific protein profiles. One protein peak (relative molecular mass, Mr, 11,537 Da) was identified in plasma from women with ovarian cancer but not in controls. Two peaks, Mr 5,147 and 8,780 Da, were present in the plasma of controls but not of women with ovarian cancer. After a training analysis, classification analysis generated by univariant or linear combination split was performed to reach a discriminant protein signature pattern. After cross validation, a sensitivity of 84% and specificity of 89% for all studied cases and controls was reached. Conclusion: This study clearly demonstrates that the combined technology of SELDI-TOF MS and artificial intelligence is effective in distinguishing protein expression between normal and ovarian cancer plasma. The identified protein peaks may be candidate proteins for early detection of ovarian cancer or evaluation of therapeutic response.http://www.sciencedirect.com/science/article/pii/S1028455909601868protein chipovarian cancerSELDI-TOF mass spectrometry |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shao-Pai Wu Ya-Wen Lin Hung-Cheng Lai Tang-Yuan Chu Yu-Liang Kuo Hang-Seng Liu |
spellingShingle |
Shao-Pai Wu Ya-Wen Lin Hung-Cheng Lai Tang-Yuan Chu Yu-Liang Kuo Hang-Seng Liu Seldi-tof MS Profiling of Plasma Proteins in Ovarian Cancer Taiwanese Journal of Obstetrics & Gynecology protein chip ovarian cancer SELDI-TOF mass spectrometry |
author_facet |
Shao-Pai Wu Ya-Wen Lin Hung-Cheng Lai Tang-Yuan Chu Yu-Liang Kuo Hang-Seng Liu |
author_sort |
Shao-Pai Wu |
title |
Seldi-tof MS Profiling of Plasma Proteins in Ovarian Cancer |
title_short |
Seldi-tof MS Profiling of Plasma Proteins in Ovarian Cancer |
title_full |
Seldi-tof MS Profiling of Plasma Proteins in Ovarian Cancer |
title_fullStr |
Seldi-tof MS Profiling of Plasma Proteins in Ovarian Cancer |
title_full_unstemmed |
Seldi-tof MS Profiling of Plasma Proteins in Ovarian Cancer |
title_sort |
seldi-tof ms profiling of plasma proteins in ovarian cancer |
publisher |
Elsevier |
series |
Taiwanese Journal of Obstetrics & Gynecology |
issn |
1028-4559 |
publishDate |
2006-03-01 |
description |
Objective: Proteomic profiling of plasma or serum is a technique to identify new biomarkers in disease. The objective of this study was to identify new plasma biomarkers in ovarian cancer patients using mass spectrometry protein profiling and artificial intelligence.
Methods: A total of 65 plasma samples obtained from women with ovarian cancer (n = 35) and age-matched disease-free controls (n = 30) were applied to anion exchange protein chips for protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS).
Results: SELDI-TOF MS was highly reproducible in detecting ovarian tumor-specific protein profiles. One protein peak (relative molecular mass, Mr, 11,537 Da) was identified in plasma from women with ovarian cancer but not in controls. Two peaks, Mr 5,147 and 8,780 Da, were present in the plasma of controls but not of women with ovarian cancer. After a training analysis, classification analysis generated by univariant or linear combination split was performed to reach a discriminant protein signature pattern. After cross validation, a sensitivity of 84% and specificity of 89% for all studied cases and controls was reached.
Conclusion: This study clearly demonstrates that the combined technology of SELDI-TOF MS and artificial intelligence is effective in distinguishing protein expression between normal and ovarian cancer plasma. The identified protein peaks may be candidate proteins for early detection of ovarian cancer or evaluation of therapeutic response. |
topic |
protein chip ovarian cancer SELDI-TOF mass spectrometry |
url |
http://www.sciencedirect.com/science/article/pii/S1028455909601868 |
work_keys_str_mv |
AT shaopaiwu selditofmsprofilingofplasmaproteinsinovariancancer AT yawenlin selditofmsprofilingofplasmaproteinsinovariancancer AT hungchenglai selditofmsprofilingofplasmaproteinsinovariancancer AT tangyuanchu selditofmsprofilingofplasmaproteinsinovariancancer AT yuliangkuo selditofmsprofilingofplasmaproteinsinovariancancer AT hangsengliu selditofmsprofilingofplasmaproteinsinovariancancer |
_version_ |
1725722136829493248 |